Home
FTRE
FTRE News

Latest Fortrea Holdings Inc. (FTRE) News on September 18, 2025

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 days ago

Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Jefferies Raises Fortrea (FTRE) PT to $9.50 Amid Improved Biotech Funding

Insider Monkey

7 days ago

Jefferies Raises Fortrea (FTRE) PT to $9.50 Amid Improved Biotech Funding

Adaptive Biotechnologies (ADPT) Surges 12.5%: Is This an Indication of Further Gains?

Zacks

3 months ago

Adaptive Biotechnologies (ADPT) Surges 12.5%: Is This an Indication of Further Gains?

Argus Research

3 months ago

FTRE: Rating decreased to a SELL

Is It Time To Consider Buying Fortrea Holdings Inc. (NASDAQ:FTRE)?

Simply Wall St.

3 months ago

Is It Time To Consider Buying Fortrea Holdings Inc. (NASDAQ:FTRE)?

Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin

GlobeNewswire

3 months ago

Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin

FTRE vs. ILMN: Which Stock Should Value Investors Buy Now?

Zacks

3 months ago

FTRE vs. ILMN: Which Stock Should Value Investors Buy Now?

Oracle reports Q4 beat, BioNTech to acquire CureVac: Morning Buzz

TipRanks

3 months ago

Oracle reports Q4 beat, BioNTech to acquire CureVac: Morning Buzz

Fortrea Adopts Limited-Duration Stockholder Rights Plan

GlobeNewswire

3 months ago

Fortrea Adopts Limited-Duration Stockholder Rights Plan

Fortrea Names Anshul Thakral Chief Executive Officer

GlobeNewswire

3 months ago

Fortrea Names Anshul Thakral Chief Executive Officer

Argus Research

3 months ago

FTRE: Rating increased to a HOLD

Fortrea to Present at the Jefferies Global Healthcare Conference

GlobeNewswire

3 months ago

Fortrea to Present at the Jefferies Global Healthcare Conference

Argus Research

4 months ago

FTRE: Rating decreased to a SELL

Fortrea Holdings First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

4 months ago

Fortrea Holdings First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Argus Research

4 months ago

FTRE: Lowering target price to $5.00

GuruFocus.com

4 months ago

Fortrea Holdings Inc (FTRE) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...

Morningstar Research

4 months ago

Analyst Report: Fortrea Holdings Inc.

Fortrea Reports First Quarter 2025 Results

GlobeNewswire

4 months ago

Fortrea Reports First Quarter 2025 Results

Fortrea Announces CEO Stepping Down

GlobeNewswire

4 months ago

Fortrea Announces CEO Stepping Down

Argus Research

4 months ago

FTRE: Lowering target price to $6.00

Fortrea Holdings Inc.'s (NASDAQ:FTRE) Intrinsic Value Is Potentially 84% Above Its Share Price

Simply Wall St.

4 months ago

Fortrea Holdings Inc.'s (NASDAQ:FTRE) Intrinsic Value Is Potentially 84% Above Its Share Price

Fortrea Named a Leader in Everest Group’s Pharmacovigilance Operations PEAK Matrix® Assessment 2025

GlobeNewswire

5 months ago

Fortrea Named a Leader in Everest Group’s Pharmacovigilance Operations PEAK Matrix® Assessment 2025

Argus Research

5 months ago

FTRE: Raising target price to $6.00

Argus Research

5 months ago

FTRE: Lowering target price to $5.00

Fortrea Announces Date for First Quarter 2025 Financial Results and Conference Call

GlobeNewswire

5 months ago

Fortrea Announces Date for First Quarter 2025 Financial Results and Conference Call

Argus Research

5 months ago

FTRE: Rating decreased to a HOLD

Argus Research

6 months ago

FTRE: Lowering target price to $8.00

Argus Research

6 months ago

FTRE: Lowering target price to $10.00

Morningstar Research

6 months ago

Analyst Report: Fortrea Holdings Inc.

Argus Research

6 months ago

FTRE: Lowering target price to $12.00

GuruFocus.com

7 months ago

Fortrea Holdings Inc (FTRE) Q4 2024 Earnings Call Highlights: Navigating Challenges with ...

Morningstar Research

7 months ago

Analyst Report: Fortrea Holdings Inc.

Fortrea Reports Fourth Quarter and Full-Year 2024 Results; Issues Full-Year 2025 Guidance

GlobeNewswire

7 months ago

Fortrea Reports Fourth Quarter and Full-Year 2024 Results; Issues Full-Year 2025 Guidance

Argus Research

7 months ago

FTRE: Lowering target price to $15.00

Fortrea to Add Erin L. Russell to Board of Directors

GlobeNewswire

7 months ago

Fortrea to Add Erin L. Russell to Board of Directors

Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical Research

GlobeNewswire

7 months ago

Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical Research

Argus Research

7 months ago

FTRE: What does Argus have to say about FTRE?

Morningstar Research

7 months ago

Analyst Report: Fortrea Holdings Inc.

Argus Research

7 months ago

FTRE: Lowering target price to $17.00

Several Insiders Invested In Fortrea Holdings Flagging Positive News

Simply Wall St.

8 months ago

Several Insiders Invested In Fortrea Holdings Flagging Positive News

Fortrea Announces Date for Fourth Quarter and Full Year 2024 Financial Results and Conference Call

GlobeNewswire

8 months ago

Fortrea Announces Date for Fourth Quarter and Full Year 2024 Financial Results and Conference Call

Argus Research

8 months ago

FTRE: Raising target price to $20.00

Argus Research

8 months ago

FTRE: Lowering target price to $19.00

Argus Research

9 months ago

FTRE: Lowering target price to $20.00

Argus Research

9 months ago

FTRE: Lowering target price to $21.00

Argus Research

9 months ago

FTRE: Lowering target price to $22.00

Fortrea downgraded to Neutral from Outperform at Baird

TipRanks

9 months ago

Fortrea downgraded to Neutral from Outperform at Baird

Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors

GlobeNewswire

9 months ago

Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors

Argus Research

9 months ago

FTRE: Raising target price to $23.00

Argus Research

10 months ago

FTRE: Raising target price to $22.00

Fortrea to Present at the Evercore HealthCONx Conference

GlobeNewswire

10 months ago

Fortrea to Present at the Evercore HealthCONx Conference

Fortrea to Present at the Citi Global Healthcare Conference

GlobeNewswire

10 months ago

Fortrea to Present at the Citi Global Healthcare Conference

Argus Research

10 months ago

FTRE: Raising target price to $23.00

US$24.56 - That's What Analysts Think Fortrea Holdings Inc. (NASDAQ:FTRE) Is Worth After These Results

Simply Wall St.

10 months ago

US$24.56 - That's What Analysts Think Fortrea Holdings Inc. (NASDAQ:FTRE) Is Worth After These Results

Fortrea price target raised to $30 from $28 at Baird

TipRanks

10 months ago

Fortrea price target raised to $30 from $28 at Baird

Morningstar Research

10 months ago

Analyst Report: Fortrea Holdings Inc.

Fortrea Holdings Third Quarter 2024 Earnings: EPS Beats Expectations

Simply Wall St.

10 months ago

Fortrea Holdings Third Quarter 2024 Earnings: EPS Beats Expectations

GuruFocus.com

10 months ago

Fortrea Holdings Inc (FTRE) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing ...

GuruFocus.com

10 months ago

Fortrea Stock Explodes 37%--Investors Are Eyeing Massive Gains

Fortrea Reports Third Quarter 2024 Results

GlobeNewswire

10 months ago

Fortrea Reports Third Quarter 2024 Results

Argus Research

10 months ago

FTRE: Lowering target price to $18.00

Fortrea Releases Inaugural Corporate Social Responsibility Report

GlobeNewswire

a year ago

Fortrea Releases Inaugural Corporate Social Responsibility Report

Fortrea Announces Date for Third Quarter 2024 Financial Results and Conference Call

GlobeNewswire

a year ago

Fortrea Announces Date for Third Quarter 2024 Financial Results and Conference Call

Argus Research

a year ago

FTRE: Lowering target price to $20.00

Argus Research

a year ago

FTRE: What does Argus have to say about FTRE?

Argus Research

a year ago

FTRE: Rating decreased to a HOLD

Fortrea Holdings Second Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

a year ago

Fortrea Holdings Second Quarter 2024 Earnings: Misses Expectations

Insider Stock Buying Reaches US$1.08m On Fortrea Holdings

Simply Wall St.

a year ago

Insider Stock Buying Reaches US$1.08m On Fortrea Holdings

Morningstar Research

a year ago

Analyst Report: Fortrea Holdings Inc.

Morningstar Research

a year ago

Analyst Report: Fortrea Holdings Inc.

Fortrea Reports Second Quarter 2024 Results

GlobeNewswire

a year ago

Fortrea Reports Second Quarter 2024 Results

Argus Research

a year ago

FTRE: Lowering target price to $27.00

Fortrea Announces Date for Second Quarter 2024 Financial Results and Conference Call

GlobeNewswire

a year ago

Fortrea Announces Date for Second Quarter 2024 Financial Results and Conference Call

Argus Research

a year ago

FTRE: Raising target price to $31.00

Fortrea Appoints Robert Parks as Chief Accounting Officer

GlobeNewswire

a year ago

Fortrea Appoints Robert Parks as Chief Accounting Officer

Argus Research

a year ago

FTRE: What does Argus have to say about FTRE?

Argus Research

a year ago

FTRE: Raising target price to $25.00

Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery

GlobeNewswire

a year ago

Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery

Fortrea to Participate in Virtual Fireside Chat with Evercore ISI

GlobeNewswire

a year ago

Fortrea to Participate in Virtual Fireside Chat with Evercore ISI

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

PR Newswire

a year ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

Business Wire

a year ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts

AFP

a year ago

New Zealand scraps plan to tax livestock burps, farts

Business Wire

a year ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

The Wall Street Journal

a year ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

UK Unemployment Rises in Sign Inflationary Pressures Cool

Bloomberg

a year ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Simply Wall St.

a year ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Here's Why New Toyo International Holdings (SGX:N08) Has Caught The Eye Of Investors

Simply Wall St.

a year ago

Here's Why New Toyo International Holdings (SGX:N08) Has Caught The Eye Of Investors

Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

GlobeNewswire

a year ago

Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

Fortrea to Present at the Jefferies Global Healthcare Conference

GlobeNewswire

a year ago

Fortrea to Present at the Jefferies Global Healthcare Conference

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 05/31/2024

Fortrea Holdings Inc (FTRE) CEO Acquires Additional Shares

GuruFocus.com

a year ago

Fortrea Holdings Inc (FTRE) CEO Acquires Additional Shares

Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research

GlobeNewswire

a year ago

Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research

Morningstar Research

a year ago

Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

Fortrea Appoints Machelle Sanders to Board of Directors

GlobeNewswire

a year ago

Fortrea Appoints Machelle Sanders to Board of Directors

Morningstar Research

a year ago

Analyst Report: Fortrea Holdings Inc.

An Intrinsic Calculation For Fortrea Holdings Inc. (NASDAQ:FTRE) Suggests It's 48% Undervalued

Simply Wall St.

a year ago

An Intrinsic Calculation For Fortrea Holdings Inc. (NASDAQ:FTRE) Suggests It's 48% Undervalued

Fortrea Holdings First Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

a year ago

Fortrea Holdings First Quarter 2024 Earnings: Misses Expectations

GuruFocus.com

a year ago

Fortrea Holdings Inc (FTRE) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...

Morningstar Research

a year ago

Analyst Report: Fortrea Holdings Inc.

Fortrea Reports First Quarter 2024 Results

GlobeNewswire

a year ago

Fortrea Reports First Quarter 2024 Results

Share on Social Networks: